DATASHEET
Host:
Rabbit
Target Protein:
Cyclin D3
Clonality:
Monoclonal
Isotype:
IgG
Entrez Gene:
896
Swiss Prot:
P30281
Source:
Recombinant human Cyclin D3 protein, around C-terminal 200aa.
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D3/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.
VALIDATION IMAGES
Lane 1: Jurkat; Lane 2: Hela lysates probed with Cyclin D3 (4A8) Monoclonal Antibody (bsm-52047R) at 1:1000 overnight at 4˚C. Followed by a conjugated secondary antibody.
A431 cells were stained with Cyclin D3 (4A8) Monoclonal Antibody (bsm-52047R) at [1:200] incubated overnight at 4C, followed by secondary antibody incubation, DAPI staining of the nuclei and detection.
Lane 1: Human MOLT-4 cell lysates; Lane 2: Human A549 cell lysates; Lane 3: Human Jurkat cell lysates; Lane 4: Human Panc-1 cell lysates probed with Cyclin D3 Monoclonal Antibody, Unconjugated (bsm-52047R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.